Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.2045 | 0.311 | 0.5 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.2003 | 0.3002 | 0.3002 |
Echinococcus multilocularis | carbonic anhydrase II | 0.2003 | 0.3002 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.2003 | 0.3002 | 0.5 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.2684 | 0.475 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.2003 | 0.3002 | 0.5 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.2003 | 0.3002 | 0.5 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.2003 | 0.3002 | 1 |
Plasmodium falciparum | carbonic anhydrase | 0.0834 | 0 | 0.5 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.4728 | 1 | 0.5 |
Leishmania major | carbonic anhydrase family protein, putative | 0.4728 | 1 | 1 |
Echinococcus granulosus | carbonic anhydrase II | 0.2003 | 0.3002 | 1 |
Mycobacterium ulcerans | carbonic anhydrase | 0.4728 | 1 | 1 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.2003 | 0.3002 | 1 |
Schistosoma mansoni | carbonic anhydrase | 0.4728 | 1 | 1 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.2003 | 0.3002 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0834 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2045 | 0.311 | 0.5 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.2003 | 0.3002 | 0.3002 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.2003 | 0.3002 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.